Welcome

Modules

SEE ALL
  • view presentation
    EMPEROR-Reduced

    The EMPEROR-Reduced trial evaluated the efficacy and safety of empagli

  • view presentation
    Safety aspects of SGLT2 inhibitors for treatment of heart failure

    Understanding the safety profile of a drug is essential for the treatm

  • view presentation
    SGLT2 inhibitors as a potential treatment option in heart failure

    There is a need for treatments that improve outcomes for patients with